Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2006-7-10
pubmed:abstractText
In the sub-Saharan African meningitis belt there is a region of hyperendemic and epidemic meningitis stretching from Senegal to Ethiopia. The public health approaches to meningitis epidemics, including those related to vaccine use, have assumed that Neisseria meningitidis serogroup A will cause the most disease. During 2001 and 2002, the first large-scale epidemics of serogroup W135 meningitis in sub-Saharan Africa were reported from Burkina Faso. The occurrence of N. meningitidis W135 epidemics has led to a host of new issues, including the need for improved laboratory diagnostics for identifying serogroups during epidemics, an affordable supply of serogroup W135-containing polysaccharide vaccine for epidemic control where needed, and re-evaluating the long-term strategy of developing a monovalent A conjugate vaccine for the region. This review summarizes the existing data on N. meningitidis W135 epidemiology, immunology and vaccines as they relate to meningitis in sub-Saharan Africa.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1744-8395
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
319-36
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:16827617-Adolescent, pubmed-meshheading:16827617-Adult, pubmed-meshheading:16827617-Africa South of the Sahara, pubmed-meshheading:16827617-Carrier State, pubmed-meshheading:16827617-Child, pubmed-meshheading:16827617-Child, Preschool, pubmed-meshheading:16827617-Clinical Trials as Topic, pubmed-meshheading:16827617-Communicable Diseases, Emerging, pubmed-meshheading:16827617-Disease Outbreaks, pubmed-meshheading:16827617-Humans, pubmed-meshheading:16827617-Infant, pubmed-meshheading:16827617-Meningitis, Meningococcal, pubmed-meshheading:16827617-Meningococcal Vaccines, pubmed-meshheading:16827617-Neisseria meningitidis, Serogroup W-135, pubmed-meshheading:16827617-Seroepidemiologic Studies, pubmed-meshheading:16827617-Serotyping, pubmed-meshheading:16827617-Vaccination
pubmed:year
2006
pubmed:articleTitle
Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.
pubmed:affiliation
Agence de Médecine Préventive, 25 du Dr Roux, 75724 Paris cedex 15, France. jmueller@aamp.org
pubmed:publicationType
Journal Article, Review